1.
Hematol Oncol Stem Cell Ther
; 11(1): 44-46, 2018 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29079126
RESUMEN
The literature reports an incidence of Pure Red Cell Aplasia (PRCA) ranging from 6-30% of all cases of ABO-incompatible HSCT. Although most patients resolve spontaneously after withdrawal immunosuppression, some of them require more aggressive treatment to manage this condition.